Q2 EPS Estimate for Kezar Life Sciences Raised by Analyst
Kezar Life Sciences, Inc. (NASDAQ:KZR – Free Report) – Equities researchers at William Blair increased their Q2 2025 EPS estimates for Kezar Life Sciences in a note issued to investors on Tuesday, May 13th. William Blair analyst M. Phipps now expects that the company will post earnings of ($2.04) per share for the quarter, up […]
